> > Getting Support

Navigation icon: Step 1 Getting Your Factor
Navigation icon: Step 1 Getting Your Factor
Navigation icon: Step 2 Preparing for an Infusion
Navigation icon: Step 2 Preparing for an Infusion
Navigation icon: Step 3 Performing an Infusion
Navigation icon: Step 3 Performing an Infusion
Navigation icon: Step 4 Getting Support
Navigation icon: Step 4 Getting Support

SUPPORT AND RESOURCES FOR YOU

As you travel along your hemophilia journey, Novo Nordisk is here to help with product support and educational resources.

STAY IN THE KNOW. SIGN UP TO GET THE LATEST UPDATES ON REBINYN®

rebinyn updates

Sign Up Now

LOOKING FOR RESOURCES TO HELP YOU MANAGE YOUR HEMOPHILIA?

hemophilia resources

Check Out Our Support Offerings

DO YOU PLAN ON TRAVELING?

With a Rebinyn® Travel Case, your factor will be ready when you are. This portable, reusable travel case helps store other supplies conveniently, at home or while traveling.

To order a Travel Case, please contact your local Rare Blood Community Liaison (RBCL).

speak to a representative

HAVE A QUESTION? NOVO NORDISK IS HERE TO HELP YOU

Contact your Rare Blood Community Liaison (RBCL) for answers to your questions.

Contact Us

Selected Important Safety Information

What is the most important information I need to know about Rebinyn®?

  • Do not attempt to do an infusion yourself unless you have been taught how by your healthcare provider or hemophilia treatment center. Carefully follow your healthcare provider’s instructions regarding the dose and schedule for infusing Rebinyn®.

Who should not use Rebinyn®?
Do not use Rebinyn® if you:

  • are allergic to Factor IX or any of the other ingredients of Rebinyn®.
  • are allergic to hamster proteins.
     

Indications and Usage

What is Rebinyn®, Coagulation Factor IX (Recombinant), GlycoPEGylated?
Rebinyn® is an injectable medicine used to replace clotting Factor IX that is missing in patients with hemophilia B. Rebinyn® is used to treat, prevent, or reduce the frequency (number) of bleeding episodes in people with hemophilia B. Your healthcare provider may give you Rebinyn® when you have surgery. Rebinyn® is not used for immune tolerance therapy.

Important Safety Information

What is the most important information I need to know about Rebinyn®?

  • Do not attempt to do an infusion yourself unless you have been taught how by your healthcare provider or hemophilia treatment center. Carefully follow your healthcare provider’s instructions regarding the dose and schedule for infusing Rebinyn®.

Who should not use Rebinyn®?
Do not use Rebinyn® if you:

  • are allergic to Factor IX or any of the other ingredients of Rebinyn®.
  • are allergic to hamster proteins.

What should I tell my healthcare provider before using Rebinyn®?
Tell your healthcare provider if you:

  • have or have had any medical conditions.
  • take any medicines, including non-prescription medicines and dietary supplements.
  • are nursing, pregnant, or plan to become pregnant.
  • have been told you have inhibitors to Factor IX.

How should I use Rebinyn®?

  • Rebinyn® is given as an infusion into the vein.
  • Call your healthcare provider right away if your bleeding does not stop after taking Rebinyn®.
  • Do not stop using Rebinyn® without consulting your healthcare provider.

What are the possible side effects of Rebinyn®?

  • Common side effects include infusion site reaction (bruising, bleeding, swelling, pain, or redness), itching, and rash.
  • Your body can also make antibodies called “inhibitors” against Factor IX, including Rebinyn®, which may stop Rebinyn® from working properly. Your healthcare provider may need to test your blood for inhibitors from time to time.
  • Call your healthcare provider right away or get emergency treatment right away if you get, for example, any of the following signs of an allergic reaction: hives, chest tightness, wheezing, difficulty breathing, and/or swelling of the face.
  • You may be at an increased risk of forming blood clots in your body, especially if you have risk factors for developing blood clots. Call your healthcare provider if you have chest pain, difficulty breathing, leg tenderness, or swelling.
  • Animals given repeat doses of Rebinyn® showed Polyethylene Glycol (PEG) in certain cells in the brain. The potential human implications of these animal tests are unknown.
     

Please click here for Prescribing Information.

Rebinyn® is a prescription medication.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.